ALBO - Albireo Pharma EPS misses by $0.45 beats on revenue November, 05 2020 07:47 AM Albireo Pharma Inc. Albireo Pharma (ALBO): Q3 GAAP EPS of -$1.96 misses by $0.45.Revenue of $2.13M (+53.2% Y/Y) beats by $0.5M.Press Release For further details see: Albireo Pharma EPS misses by $0.45, beats on revenue